Scytosiphon lomentaria Extract Ameliorates Obesity and Modulates Gut Microbiota in High-Fat-Diet-Fed Mice.
Jing YanJinwoo BakYula GoJumin ParkMinkyoung ParkHae Jeung LeeHyemee KimPublished in: Nutrients (2023)
Scytosiphon lomentaria (SL) is a brown seaweed with antioxidant and anti-inflammatory properties; however, its effects on obesity are unknown. In this research, we investigated the anti-obesity properties and underlying mechanisms of the SL extract in vitro and in vivo. In 3T3-L1 preadipocytes, SL extract inhibited lipid accumulation, decreased the expression of Acc1 , C/ebpa , Pparg mRNA and p-ACC1, and increased the expression of Ucp1 mRNA, UCP1 and p-AMPK. In animal experiments, mice were fed a chow diet, a high-fat diet (HF; 60% of calories as fat), and high-fat diet with SL extract (150 and 300 mg/kg body weight) for eight weeks ( n = 10/group). SL extract reduced HF-induced weight gain, epididymal fat weight, fat cell size, LDL-C, leptin, fasting glucose, and glucose tolerance. In addition, SL extract had comparable effects on mRNA expression in WAT and liver to those observed in vitro, thereby inhibiting p-ACC1/ACC1 and increasing p-AMPK/AMPK and UCP1 expression. Furthermore, SL extract decreased HF-induced Firmicutes/Bacteroidetes ratio and reversed HF-reduced Bacteroides spp., Bacteroides vulgatus , and Faecalibacterium prausnitzii . These findings suggest that SL extract can aid in weight loss in mice fed a high-fat diet by altering adipogenic and thermogenic pathways, as well as gut microbiota composition.
Keyphrases
- high fat diet
- insulin resistance
- adipose tissue
- high fat diet induced
- anti inflammatory
- weight loss
- weight gain
- oxidative stress
- skeletal muscle
- metabolic syndrome
- poor prognosis
- body weight
- type diabetes
- body mass index
- bariatric surgery
- diabetic rats
- heart failure
- birth weight
- signaling pathway
- blood glucose
- preterm birth
- high glucose
- cell therapy
- roux en y gastric bypass
- stem cells
- gastric bypass
- long non coding rna
- glycemic control
- atrial fibrillation
- drug induced
- obese patients
- mesenchymal stem cells